Select Publications
Book Chapters
2024, 'Management of Primary Pancreatic Cancer', in Jankowski JAZ (ed.), Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach, Wiley, pp. 386 - 406, http://dx.doi.org/10.1002/9781119756422.ch20
,2013, 'Breaking bad news and truth disclosure in Australia', in New Challenges in Communication with Cancer Patients, pp. 377 - 387, http://dx.doi.org/10.1007/978-1-4614-3369-9_31
,2010, 'Interferon Therapy and Cancer', in Oldham RK (ed.), Cancer Biotherapy: Principles and Practice, Springer, New York, pp. 277 - 302
,2009, 'Complications of Lip Surgery', in Complications in Head and Neck Surgery with CD Image Bank, pp. 251 - 256, http://dx.doi.org/10.1016/B978-141604220-4.50026-2
,2009, 'Tumors of the hypopharynx', in Principles and Practice of Head and Neck Surgery and Oncology, Second Edition, pp. 233 - 256
,2000, 'Chemotherapy and radiotherapy for pancreatic cancer', in Yip D (ed.), , John Wiley & Sons, Ltd, http://dx.doi.org/10.1002/14651858.cd002093
,1998, 'Interferons: Therapy in Cancer', in Principles of Cancer Biotherapy, Springer Netherlands, pp. 266 - 283, http://dx.doi.org/10.1007/978-94-009-0029-5_11
,Journal articles
2024, 'Lymphatic mapping in second primary or recurrent oral cavity cancer with prior neck treatment: A case series and scoping review', Oral Oncology, 159, http://dx.doi.org/10.1016/j.oraloncology.2024.107077
,2024, 'Smoking and alcohol by HPV status in head and neck cancer: a Mendelian randomization study', Nature Communications, 15, http://dx.doi.org/10.1038/s41467-024-51679-x
,2024, 'Nodal Metastases in Stage 3 Head and Neck Melanoma: Patterns of Metastases and Patterns of Failure', Laryngoscope, 134, pp. 4292 - 4297, http://dx.doi.org/10.1002/lary.31515
,2024, 'Causes and impact of delays during the COVID-19 pandemic on head and neck cancer diagnosis', Head and Neck, 46, pp. 2197 - 2205, http://dx.doi.org/10.1002/hed.27784
,2024, 'From ownership to custodianship of tumor biopsy tissue in genomic testing: A mixed methods study of patient views', Oncologist, 29, pp. e1169 - e1179, http://dx.doi.org/10.1093/oncolo/oyae074
,2024, 'Validity of Patient-Reported Outcome Measures in Evaluating Nerve Damage Following Chemotherapy', JAMA Network Open, 7, pp. e2424139, http://dx.doi.org/10.1001/jamanetworkopen.2024.24139
,2024, 'Delphi studies in social and health sciences—Recommendations for an interdisciplinary standardized reporting (DELPHISTAR). Results of a Delphi study', PLoS ONE, 19, http://dx.doi.org/10.1371/journal.pone.0304651
,2024, 'Length of Stay Prediction Models for Oral Cancer Surgery: Machine Learning, Statistical and ACS-NSQIP', Laryngoscope, 134, pp. 3664 - 3672, http://dx.doi.org/10.1002/lary.31443
,2024, 'Ultrasound Imaging in Active Surveillance of Small, Low-Risk Papillary Thyroid Cancer', Korean Journal of Radiology, 25, pp. 749 - 755, http://dx.doi.org/10.3348/kjr.2024.0148
,2024, 'Changes in New Patient Consultations During the COVID-19 Pandemic at a Canadian Comprehensive Cancer Center', JNCCN Journal of the National Comprehensive Cancer Network, 22, http://dx.doi.org/10.6004/jnccn.2024.7003
,2024, 'Transoral Robotic Surgery and Radiation Volume Deintensification in Unknown Primary Squamous Cell Carcinoma of the Neck: The Phase 2 FIND Nonrandomized Controlled Trial', JAMA Otolaryngology - Head and Neck Surgery, 150, pp. 463 - 471, http://dx.doi.org/10.1001/jamaoto.2024.0423
,2024, 'Development and Standardization of an Osteoradionecrosis Classification System in Head and Neck Cancer: Implementation of a Risk-Based Model', Journal of Clinical Oncology, 42, pp. 1922 - 1933, http://dx.doi.org/10.1200/JCO.23.01951
,2024, 'Identifying optimized assessment of nerve damage during chemotherapy.', Journal of Clinical Oncology, 42, pp. 12016 - 12016, http://dx.doi.org/10.1200/jco.2024.42.16_suppl.12016
,2024, 'Decision Regret Following the Choice of Surgery or Active Surveillance for Small, Low-Risk Papillary Thyroid Cancer: A Prospective Cohort Study', Thyroid, 34, pp. 626 - 634, http://dx.doi.org/10.1089/thy.2023.0634
,2024, 'Characterising vincristine-induced peripheral neuropathy in adults: symptom development and long-term persistent outcomes', Supportive Care in Cancer, 32, http://dx.doi.org/10.1007/s00520-024-08484-5
,2024, 'Plasma Lipidomic Profiling Identifies Elevated Triglycerides as Potential Risk Factor in Chemotherapy-Induced Peripheral Neuropathy', JCO Precision Oncology, 8, http://dx.doi.org/10.1200/PO.23.00690
,2024, 'Impact of Pain on Symptom Burden in Chemotherapy-Induced Peripheral Neurotoxicity', JNCCN Journal of the National Comprehensive Cancer Network, 22, pp. 108 - 116, http://dx.doi.org/10.6004/jnccn.2023.7083
,2024, 'Upper-limb dysfunction in cancer survivors with chemotherapy-induced peripheral neurotoxicity', Journal of the Neurological Sciences, 457, http://dx.doi.org/10.1016/j.jns.2023.122862
,2024, 'Ripretinib versus sunitinib in gastrointestinal stromal tumor: ctDNA biomarker analysis of the phase 3 INTRIGUE trial', Nature Medicine, 30, pp. 498 - 506, http://dx.doi.org/10.1038/s41591-023-02734-5
,2024, 'Abstract B062: CRO67 has therapeutic potential against pancreatic tumor cells and cancer associated fibroblasts', Cancer Research, 84, pp. B062 - B062, http://dx.doi.org/10.1158/1538-7445.panca2023-b062
,2024, 'A Comparison of Transoral Versus Transcervical Surgical Approaches to Retropharyngeal Lymphadenectomy: A Scoping Review', Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale, 53, http://dx.doi.org/10.1177/19160216241265092
,2024, 'A multi-institutional feasibility lead-in trial of lymphatic mapping with SPECT–CT for evaluating contralateral disease in lateralized oropharynx cancer using 99m-technetium sulfur colloid', Head and Neck, http://dx.doi.org/10.1002/hed.27871
,2024, 'Clinical Predictors of Cisplatin Chemoradiation-Induced Ototoxicity in HPV-Positive Oropharyngeal Squamous Cell Carcinoma: A Case-Control Study', Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale, 53, http://dx.doi.org/10.1177/19160216241248671
,2024, 'Impact of Postoperative Neck Radiotherapy Volumes on Long-Term Unstimulated Saliva Flow Following Primary Surgery and Ipsilateral Neck Dissection for Oral Cavity Squamous Cell Carcinoma', Head and Neck, http://dx.doi.org/10.1002/hed.27988
,2024, 'Impact of Surgeon-Radiation Oncology Dyads in Oral Cavity Cancer Outcomes', Annals of Surgical Oncology, http://dx.doi.org/10.1245/s10434-024-16385-4
,2024, 'Impact of Transoral Robotic Surgery Versus Radiation on Swallowing Function in Oropharyngeal Cancer Patients: A Sub-Study From a Randomized Trial', Head and Neck, http://dx.doi.org/10.1002/hed.27986
,2024, 'INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer', Journal of Clinical Oncology, http://dx.doi.org/10.1200/JCO.24.00055
,2024, 'Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Final Results of the ORATOR Randomized Trial', Journal of Clinical Oncology, http://dx.doi.org/10.1200/JCO.24.00119
,2024, 'Reply to E. Topkan et al', Journal of Clinical Oncology, http://dx.doi.org/10.1200/JCO-24-01520
,2024, 'Sleep dysfunction associated with worse chemotherapy-induced peripheral neurotoxicity functional outcomes', Supportive Care in Cancer, 32, http://dx.doi.org/10.1007/s00520-023-08245-w
,2024, '1513P Impact of symptom and functional burden on survival in pancreatic ductal adenocarcinoma (PDAC)', Annals of Oncology, 35, pp. S925 - S925, http://dx.doi.org/10.1016/j.annonc.2024.08.1576
,2024, '636P Tucatinib and trastuzumab in advanced cancers with HER2 mutations or amplification: A molecular screening and therapeutics (MoST) program substudy', Annals of Oncology, 35, pp. S505 - S505, http://dx.doi.org/10.1016/j.annonc.2024.08.703
,2023, 'INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gastro-Intestinal Trials Group (AGITG)', BMC Cancer, 23, http://dx.doi.org/10.1186/s12885-023-10642-7
,2023, 'Erlotinib Plus Gemcitabine Compared with Gemcitabine Alone in Patients with Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group', Journal of Clinical Oncology, 41, pp. 4714 - 4720, http://dx.doi.org/10.1200/JCO.22.02770
,2023, 'The protective role of postoperative radiation therapy in low and intermediate grade major salivary gland malignancies: A study of the Canadian Head and Neck Collaborative Research Initiative', Cancer, 129, pp. 3263 - 3274, http://dx.doi.org/10.1002/cncr.34932
,2023, 'Patient-reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after treatment with imatinib in INTRIGUE, a phase 3, open-label study', European Journal of Cancer, 192, http://dx.doi.org/10.1016/j.ejca.2023.113245
,2023, 'A Matched Molecular and Clinical Analysis of the Epithelioid Haemangioendothelioma Cohort in the Stafford Fox Rare Cancer Program and Contextual Literature Review', Cancers, 15, http://dx.doi.org/10.3390/cancers15174378
,2023, 'Quantifying Neck Fibrosis: Establishing the Domain Structure of the Neck Fibrosis Scale', Laryngoscope, 133, pp. 2198 - 2202, http://dx.doi.org/10.1002/lary.30497
,2023, 'HGF/c-Met pathway inhibition combined with chemotherapy increases cytotoxic T-cell infiltration and inhibits pancreatic tumour growth and metastasis', Cancer Letters, 568, http://dx.doi.org/10.1016/j.canlet.2023.216286
,2023, 'Glossectomy for the treatment of oral cavity carcinoma: Quantitative, functional and patient-reported quality of life outcomes differ by four glossectomy defects', Oral Oncology, 142, http://dx.doi.org/10.1016/j.oraloncology.2023.106431
,2023, 'The effect of exercise intensity on the inflammatory profile of cancer survivors: A randomised crossover study', European Journal of Clinical Investigation, 53, pp. e13984, http://dx.doi.org/10.1111/eci.13984
,2023, 'Value of central review of RECIST v1.1 outcomes in the AGITG INTEGRATE randomised phase 2 international trial for advanced oesophago-gastric cancer', Journal of Cancer Research and Clinical Oncology, 149, pp. 4959 - 4965, http://dx.doi.org/10.1007/s00432-022-04404-4
,2023, 'Genomic targetability and survival outcomes of biliary tract cancers (BTC): A retrospective cohort study of the Australian Molecular Screening and Therapeutics (MoST) program.', Journal of Clinical Oncology, 41, pp. 4093 - 4093, http://dx.doi.org/10.1200/jco.2023.41.16_suppl.4093
,